Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome
Alicia N Campbell, Kendall N Jung, Steven J Doyle, Ekaterina Lebayle, Barbara Corneo, Joanna Feng, Christopher L Ricupero, Jennifer M Bain, Randy Strich · 2026
Read Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome by Alicia N Campbell, Kendall N Jung, Steven J Doyle, Ekaterina Lebayle, Barbara Corneo, Joanna Feng, Christopher L Ricupero, Jennifer M Bain, Randy Strich (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13629333.txt.
Description
A single gene's variants scatter a rare brain disorder across many severities, and Alicia Campbell and eight co-authors search patient cells for the common thread in this 2026 study. Twelve cell lines, carrying eleven different variants of the MED13L gene, were grown from people with the syndrome, which mixes intellectual disability, weak muscle tone, and birth anomalies.
Every line shared two faults. Their mitochondria, the cell's power plants, underperformed: less energy output, less mitochondrial DNA, more corrosive byproducts, and dimmed instructions for building more. And a partner protein, cyclin C, kept escaping the nucleus into the cell body, where it orders mitochondria to split. Function slid further as the cells aged in the dish. The authors nominate these twin signatures as the syndrome's measurable core, and as targets for severity prediction.
Catalog record
| CREATOR | Alicia N Campbell, Kendall N Jung, Steven J Doyle, Ekaterina Lebayle, Barbara Corneo, Joanna Feng, Christopher L Ricupero, Jennifer M Bain, Randy Strich |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |